Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma inflammatory cytokines and survival of pancreatic cancer patients
Ana Babić, Nilan Schnure, Niyati Neupane, et al.
Clinical and Translational Gastroenterology (2018) Vol. 9, Iss. 4, pp. e145-e145
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia
Joseph E. Rupert, Ashok Narasimhan, Daenique H. A. Jengelley, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 6
Open Access | Times Cited: 136
Systemic treatment of pancreatic cancer revisited
Michel Ducreux, Thomas Seufferlein, Jean–Luc Van Laethem, et al.
Seminars in Oncology (2018) Vol. 46, Iss. 1, pp. 28-38
Open Access | Times Cited: 93
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Meredith L. Stone, Gregory L. Beatty
Pharmacology & Therapeutics (2019) Vol. 201, pp. 202-213
Open Access | Times Cited: 59
Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
Sharon Wei Ling Lee, R. J. Seager, Felix Litvak, et al.
Integrative Biology (2020) Vol. 12, Iss. 4, pp. 90-108
Open Access | Times Cited: 54
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer
Inna M. Chen, Nicholas Willumsen, Christian Dehlendorff, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 10, pp. 2913-2922
Open Access | Times Cited: 50
The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
Yuuki Ohara, Paloma Valenzuela, S. Perwez Hussain
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 556-569
Open Access | Times Cited: 27
Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi
Zhen‐Zhu Zhao, Baoyu Ji, Zhenzhen Wang, et al.
Phytochemistry (2023) Vol. 213, pp. 113791-113791
Closed Access | Times Cited: 14
The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets
Batoul Farran, Ganji Purnachandra Nagaraju
Cytokine & Growth Factor Reviews (2019) Vol. 48, pp. 11-23
Closed Access | Times Cited: 42
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer
Yongjian Wen, Wenhao Cai, Jingyu Yang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 29
miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer
Bing Qi, Yuqiong Wang, Xian Zhu, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer
Ana Babić, Michael H. Rosenthal, William R. Bamlet, et al.
Cancer Epidemiology Biomarkers & Prevention (2019) Vol. 28, Iss. 12, pp. 2062-2069
Open Access | Times Cited: 35
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
Agata Światły‐Błaszkiewicz, Agnieszka Horała, Jan Matysiak, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2240-2240
Open Access | Times Cited: 33
C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
Alina Frey, Daniel Martin, Louisa Abigail D’Cruz, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 18
DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization
Parthasarathy Chandrakesan, Janani Panneerselvam, Randal May, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 7, pp. 1539-1549
Open Access | Times Cited: 26
Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy
Meng Lan, Wenping Lü, Tengteng Zou, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 5, pp. 2105-2129
Open Access | Times Cited: 23
Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy
Tomoya Emori, Masahiro Itonaga, Reiko Ashida, et al.
Pancreatology (2021) Vol. 22, Iss. 2, pp. 277-285
Closed Access | Times Cited: 23
Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival
Mark B. Ulanja, Alastair E. Moody, Bryce D. Beutler, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 828-841
Open Access | Times Cited: 15
Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Italia Falcone, et al.
Journal of Oncology (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 23
Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer
Suhu Liu, Helen Gandler, Isidora Tošić, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 8, pp. 1283-1295
Open Access | Times Cited: 20
Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
Belinda Lee, Peter Gibbs
Journal of Personalized Medicine (2019) Vol. 9, Iss. 2, pp. 20-20
Open Access | Times Cited: 21
Prediagnostic Inflammation and Pancreatic Cancer Survival
Chen Yuan, Vicente Morales‐Oyarvide, Natalia Khalaf, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 9, pp. 1186-1193
Open Access | Times Cited: 17
Research progress on pharmacological effects of isoalantolactone
Lu Xu, Yanan Sun, Qihan Cai, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 5, pp. 585-592
Open Access | Times Cited: 6
Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer
Inna M. Chen, Astrid Z. Johansen, Christian Dehlendorff, et al.
Cancer Epidemiology Biomarkers & Prevention (2019) Vol. 29, Iss. 1, pp. 176-184
Closed Access | Times Cited: 17
Inflammation, Tumoral Markers and Interleukin-17, -10, and -6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis
Alina Tanțău, Daniel-Corneliu Leucuța, Marcel Tanțău, et al.
Digestive Diseases and Sciences (2020) Vol. 66, Iss. 10, pp. 3427-3438
Closed Access | Times Cited: 14
Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer
Alisa D. Kjærgaard, Inna M. Chen, Astrid Z. Johansen, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4599-4599
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top